Tai Roun Products Co.,Ltd. AI Stock Analysis
Tai Roun Products Co.,Ltd. (1220) AI Stock Analysis
Tai Roun Products Co.,Ltd.
(TWSE:1220)
Tai Roun Products scores poorly overall, driven primarily by a sharp deterioration in profitability and cash flow: margins fell to multi-year lows, net income dropped roughly 93%, and free cash flow turned negative. A conservatively financed balance sheet — low debt-to-equity of 0.22 and equity funding two-thirds of assets — provides a meaningful cushion and a track record of uninterrupted profitability suggests the downturn is cost- and cycle-driven. However, the technical picture reinforces the caution, with the price below all major moving averages and negative MACD momentum, while the P/E of about 164 leaves valuation unattractive despite a 1.9% dividend yield. A recovery in gross margin and a return to positive free cash flow would be the key signals for an improved score.
Tai Roun Products Co.,Ltd. (1220) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 1.75B
- Dividend Yield
- 2.03%
- Average Volume (3M)
- 108.19K
- Price to Earnings (P/E)
- 154.7
- Beta (1Y)
- 0.27
- Revenue Growth
- -5.47%
- EPS Growth
- -79.97%
- Country
- TW
- Employees
- 246
- Sector
- General
- Sector Strength
- 55
- Industry
- Packaged Foods
Tai Roun Products Co.,Ltd. Business Overview & Revenue Model
Company Description
Tai Roun Products Co., Ltd. operates within Taiwan, primarily focusing on the manufacturing and distribution of animal feed. Their extensive product line caters to a diverse range of livestock and aquatic species, including swine, poultry (chickens,...
Tai Roun Products Co.,Ltd. Financial Statement Overview
Summary
Financials are dominated by a severe earnings downcycle. Revenue fell 4.3% to NT$3.33 billion, gross margin compressed to 9.6% from 16.0%, and net income collapsed roughly 93% to NT$13.5 million (income statement score 33). Cash generation weakened in parallel: operating cash flow dropped to NT$48.9 million from NT$177.6 million and free cash flow turned negative at NT$-58.3 million as capex outpaced inflows (cash flow score 34). The offset is a solid balance sheet (score 70) — equity funds about two-thirds of assets and debt-to-equity is a conservative 0.22 — though debt rose about 60% year over year and return on equity fell to just 0.6%. The company has stayed profitable every year since 2020, suggesting a cyclical rather than structural problem, but earnings and cash conversion remain the clear weak link.
Income Statement
33NegativeBalance Sheet
70PositiveCash Flow
34Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.28B | 3.33B | 3.48B | 3.29B | 3.54B | 3.22B |
| Gross Profit | 329.45M | 320.53M | 557.72M | 438.09M | 308.99M | 467.13M |
| EBITDA | 136.78M | 124.39M | 387.80M | 286.86M | 169.30M | 319.61M |
| Net Income | 12.16M | 13.53M | 207.41M | 133.27M | 45.88M | 177.91M |
Balance Sheet | ||||||
| Total Assets | 3.48B | 3.53B | 3.48B | 3.20B | 3.20B | 3.29B |
| Cash, Cash Equivalents and Short-Term Investments | 476.83M | 424.60M | 529.76M | 393.38M | 235.74M | 462.45M |
| Total Debt | 577.78M | 507.51M | 317.38M | 294.87M | 330.50M | 157.75M |
| Total Liabilities | 991.87M | 968.75M | 811.77M | 661.89M | 768.89M | 698.08M |
| Stockholders Equity | 2.28B | 2.34B | 2.45B | 2.32B | 2.22B | 2.36B |
Cash Flow | ||||||
| Free Cash Flow | -296.78M | -58.34M | 76.04M | 346.65M | -215.07M | 62.35M |
| Operating Cash Flow | -194.46M | 48.91M | 177.60M | 394.46M | -103.42M | 265.39M |
| Investing Cash Flow | -70.63M | -147.44M | -94.62M | -52.73M | -94.59M | -199.24M |
| Financing Cash Flow | 235.69M | -9.91M | -10.00M | -161.49M | -63.55M | -117.51M |
Tai Roun Products Co.,Ltd. Peers Comparison
Overall Rating
TW:491172Outperform
TW:696866Neutral
TW:129559Neutral- TW:122044Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:4911 | 72Outperform | TWD 1.74B | 18.66 | ― | 4.66% | -26.73% | -34.96% |
| TW:6968 | 66Neutral | TWD 1.92B | 14.79 | ― | 3.42% | 14.75% | 11.14% |
| TW:1295 | 59Neutral | TWD 1.58B | 10.17 | ― | 7.14% | -5.28% | -27.33% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:1220 | 44Neutral | TWD 1.79B | 154.70 | ― | 2.03% | -5.47% | -79.97% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1220 | Tai Roun Products Co.,Ltd. | 9.87 | -2.66 | -21.20% | |
| TW:1295 | Synbio Tech Inc | 41.90 | -52.13 | -55.44% | |
| TW:4911 | G&E Herbal Biotechnology Co., Ltd. | 25.00 | -18.60 | -42.66% | |
| TW:6808 | 3D Global Biotech Inc. | 26.10 | -19.30 | -42.51% | |
| TW:6968 | Wonder Pets Enterprises Corp. | 38.00 | -15.85 | -29.43% | |
| TW:7705 | Mercuries F&B Co Ltd | 28.20 | -10.76 | -27.61% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026